Skip to content

BIOA - BioAge Labs, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchB

BioAge Labs, Inc

BIOA · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

B

BIOABioAge Labs, Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $25.95
52-wk low: $4.42
Prev close: $14.89
Mkt cap: $493.4M
P/S: 47.6x
P/B: 1.3x

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$156.6M

DS
D.E. Shaw
Q2 2026 13F
$18.2M
position
BA
Balyasny
Dmitry Balyasny · Q2 2026 13F

Earnings

Reported Aug 5, 2026

Earnings came in 10.8% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $493M

Valuation

P/S47.65
P/B1.28

Quality

Operating margin-1197.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: BIOA
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: DRUG MANUFACTURERS - SPECIALTY & GENERIC
Market cap: $493.39M

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

Profit margin

+0.0%

Op margin

-1197.0%

ROE

-28.2%

$17.2M

position

WC

Walleye Capital

Q2 2026 13F

$8.7M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for BIOA

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.58+10.8%

-$0.65 expected

Next report

What the street expects next

-28.2%

ROA-18.5%

Growth